Volume 32, Issue 21 (February 16, 2024)

For the full issue, subscribers click here.

Article

New US Lab Construction Leads to Oversupply

Executive Briefing

The latest on Bruker, Bio-Techne and more

Financial

Fourth Quarter Results: Bio-Techne, QIAGEN and Shimadzu

Market Profile

Organ-on-a-Chip

Industry Watch

Biopharma: Lab Transformation

Biotech: IPO Rebound

Government: Animal Testing Alternatives

Region Watch

EU: Horizon Europe’s Budget Cut

China: Solid-State Battery R&D

UK: 2022’s Health Research Funding

News

Life Science Consumables

Gene-Based Analysis

Cell-Based Analysis

Protein-Based Analysis

Sequencing

Spectroscopy

Informatics

Bottom Line

Companies’ latest financial results

< | >